Tag: aims
Pfizer aims to ship COVID vaccine doses ‘within hours’ of regulatory...
After Pfizer’s leading COVID-19 vaccine turned in strong data in a late-stage trial, the company planned to submit its program to U.S. authorities for an emergency use authorization “within...
RWJBarnabas Health’s new program aims to identify social barriers to care...
Racial and socioeconomic realities have always been tied to a person’s health, with research showing the myriad ways in which being part of a...
Bionova aims to launch commercial manufacturing by 2021 with new biologics...
Bionova already has clinical trial supply on lock, boasting more than 200 biopharma clients. Now, the Bay Area biologics maker aims to beef up...
Moderna aims for light-speed COVID-19 shot rollout with Catalent fill-finish deal
With the search for a COVID-19 vaccine in hyperdrive, drugmakers have signed a wave of massive manufacturing tie-ups to help secure capacity for a...
GlaxoSmithKline aims to make 1B doses of vaccine booster for multiple...
GlaxoSmithKline has penned deals offering its pandemic vaccine adjuvant to several developers of COVID-19 shots. And it needs to amp up supply for those...
AstraZeneca signed up to deliver U.K. shots first. Now it aims...
AstraZeneca, partnered with the University of Oxford on a leading COVID-19 vaccine candidate, has already inked a deal to supply millions of doses to the U.K. Now, the drugmaker is scouting for...
Legend aims for $100M IPO as partner J&J mulls outpatient use...
The Chinese company that originally created a CAR-T for multiple myeloma now under clinical development by Johnson & Johnson is planning to go public,...
